Stages and processes of change as predictors of drug use among methadone maintenance patients

Mark A. Belding, Martin Y. Iguchi, Richard J Lamb

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

In this study the authors evaluated the predictive validity of stages-of-change and processes-of-change measures among methadone maintenance patients. One month after treatment entry, participants completed questionnaires providing stage and process scale scores regarding readiness to discontinue polydrug use. Participants also completed an algorithm assigning them to a stage category on the basis of their stated intentions regarding quitting. The algorithm predicted urinalysis results during a 12-week posttest period; however, only 1 stage scale (contemplation) and no process scales correlated significantly with outcome. In a hierarchical regression, stage and process scale scores significantly improved prediction of posttest abstinence beyond that afforded by baseline drug-free urine rates, but this effect was attributable to the contemplation scale alone. Despite their widespread use, stage and process scales have yet to demonstrate clearly predictive validity.

Original languageEnglish (US)
Pages (from-to)65-73
Number of pages9
JournalExperimental and Clinical Psychopharmacology
Volume5
Issue number1
DOIs
StatePublished - Feb 1997
Externally publishedYes

Fingerprint

Methadone
Process Assessment (Health Care)
Urinalysis
Pharmaceutical Preparations
Urine
Therapeutics
Surveys and Questionnaires

ASJC Scopus subject areas

  • Pharmacology
  • Experimental and Cognitive Psychology

Cite this

Stages and processes of change as predictors of drug use among methadone maintenance patients. / Belding, Mark A.; Iguchi, Martin Y.; Lamb, Richard J.

In: Experimental and Clinical Psychopharmacology, Vol. 5, No. 1, 02.1997, p. 65-73.

Research output: Contribution to journalArticle

Belding, Mark A. ; Iguchi, Martin Y. ; Lamb, Richard J. / Stages and processes of change as predictors of drug use among methadone maintenance patients. In: Experimental and Clinical Psychopharmacology. 1997 ; Vol. 5, No. 1. pp. 65-73.
@article{055fe50921da40f68c84016de8cde159,
title = "Stages and processes of change as predictors of drug use among methadone maintenance patients",
abstract = "In this study the authors evaluated the predictive validity of stages-of-change and processes-of-change measures among methadone maintenance patients. One month after treatment entry, participants completed questionnaires providing stage and process scale scores regarding readiness to discontinue polydrug use. Participants also completed an algorithm assigning them to a stage category on the basis of their stated intentions regarding quitting. The algorithm predicted urinalysis results during a 12-week posttest period; however, only 1 stage scale (contemplation) and no process scales correlated significantly with outcome. In a hierarchical regression, stage and process scale scores significantly improved prediction of posttest abstinence beyond that afforded by baseline drug-free urine rates, but this effect was attributable to the contemplation scale alone. Despite their widespread use, stage and process scales have yet to demonstrate clearly predictive validity.",
author = "Belding, {Mark A.} and Iguchi, {Martin Y.} and Lamb, {Richard J}",
year = "1997",
month = "2",
doi = "10.1037/1064-1297.5.1.65",
language = "English (US)",
volume = "5",
pages = "65--73",
journal = "Experimental and Clinical Psychopharmacology",
issn = "1064-1297",
publisher = "American Psychological Association Inc.",
number = "1",

}

TY - JOUR

T1 - Stages and processes of change as predictors of drug use among methadone maintenance patients

AU - Belding, Mark A.

AU - Iguchi, Martin Y.

AU - Lamb, Richard J

PY - 1997/2

Y1 - 1997/2

N2 - In this study the authors evaluated the predictive validity of stages-of-change and processes-of-change measures among methadone maintenance patients. One month after treatment entry, participants completed questionnaires providing stage and process scale scores regarding readiness to discontinue polydrug use. Participants also completed an algorithm assigning them to a stage category on the basis of their stated intentions regarding quitting. The algorithm predicted urinalysis results during a 12-week posttest period; however, only 1 stage scale (contemplation) and no process scales correlated significantly with outcome. In a hierarchical regression, stage and process scale scores significantly improved prediction of posttest abstinence beyond that afforded by baseline drug-free urine rates, but this effect was attributable to the contemplation scale alone. Despite their widespread use, stage and process scales have yet to demonstrate clearly predictive validity.

AB - In this study the authors evaluated the predictive validity of stages-of-change and processes-of-change measures among methadone maintenance patients. One month after treatment entry, participants completed questionnaires providing stage and process scale scores regarding readiness to discontinue polydrug use. Participants also completed an algorithm assigning them to a stage category on the basis of their stated intentions regarding quitting. The algorithm predicted urinalysis results during a 12-week posttest period; however, only 1 stage scale (contemplation) and no process scales correlated significantly with outcome. In a hierarchical regression, stage and process scale scores significantly improved prediction of posttest abstinence beyond that afforded by baseline drug-free urine rates, but this effect was attributable to the contemplation scale alone. Despite their widespread use, stage and process scales have yet to demonstrate clearly predictive validity.

UR - http://www.scopus.com/inward/record.url?scp=0031029445&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031029445&partnerID=8YFLogxK

U2 - 10.1037/1064-1297.5.1.65

DO - 10.1037/1064-1297.5.1.65

M3 - Article

C2 - 9234041

AN - SCOPUS:0031029445

VL - 5

SP - 65

EP - 73

JO - Experimental and Clinical Psychopharmacology

JF - Experimental and Clinical Psychopharmacology

SN - 1064-1297

IS - 1

ER -